| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/01/1987 | EP0226985A2 Method and reagent for determining testosterone as well as a monoclonal antibody suitable for this |
| 07/01/1987 | EP0226979A2 Process for producing the protein of an aequorin activity by using a photoprotein aequorin gene |
| 07/01/1987 | EP0226888A2 Monoclonal antibodies specific to galactosyltransferase isoenzyme II and their use in cancer immunoassays |
| 07/01/1987 | EP0226846A1 Yeast production of hepatitis B Surface antigen |
| 07/01/1987 | EP0226827A2 Protection of methionine in a polypeptide chain from irreversible oxidation |
| 07/01/1987 | EP0226752A1 Method for high-level expression of polypeptides in yeast of the genus Pichia |
| 07/01/1987 | CN86108300A Mutant coding sequence |
| 07/01/1987 | CN86104458A Purification of hemoglobin and modified hemoglobin by affinity chromatography |
| 06/30/1987 | US4677197 Purification method for tumor necrosis factor |
| 06/30/1987 | US4677196 Purification and activation of proteins from insoluble inclusion bodies |
| 06/30/1987 | US4677195 Method for the purification of erythropoietin and erythropoietin compositions |
| 06/30/1987 | US4677194 Isolation of an endotoxin inactivator from human plasma |
| 06/30/1987 | US4677193 Peptides containing an aliphatic-aromatic ketone side chain |
| 06/30/1987 | US4677192 Chromatography with mixed chloroform, methanol, water, and triethylamine eluant |
| 06/30/1987 | US4677064 Human tumor necrosis factor |
| 06/30/1987 | US4677063 Human tumor necrosis factor |
| 06/30/1987 | US4677057 Diagnostic assay for the presence of apolipoproteins associated with plasma high density lipoproteins |
| 06/30/1987 | US4676983 Tumor cytostatic-citocidal factor from blood platelets |
| 06/30/1987 | CA1223513A1 Diagnosis and treatment of amyotrophic lateral sclerosis, parkinson disease and alzheimer disease by neurotrophic factors |
| 06/25/1987 | EP0192738A4 Expression of human connective tissue activator and related peptides. |
| 06/25/1987 | EP0192677A4 Processes for recovery of products from waxy barley. |
| 06/24/1987 | EP0226513A1 Peptides capable of inhibiting interactions between antigens and lymphocytes T4, products derived therefrom and their applications |
| 06/24/1987 | EP0226468A2 Detection of human cancer cells with antibodies to human cancer nucleolar antigen p145 |
| 06/24/1987 | EP0226448A2 Solubilisation of protein aggregates |
| 06/24/1987 | EP0226443A2 Human conglutinin |
| 06/24/1987 | EP0226419A2 Anti-human ovarian cancer immunotoxins and methods of use thereof |
| 06/24/1987 | EP0226418A2 Anti-human ovarian cancer immunotoxins and methods of use thereof |
| 06/24/1987 | EP0226221A1 A peptide preparation, a process for producing it and use of the peptide preparation |
| 06/24/1987 | EP0226217A2 Peptides with sulfate ester group |
| 06/24/1987 | EP0226181A2 Human placenta angiogenic factor capable of stimulating capillary endothelial cell protease synthesis, DNA synthesis and migration |
| 06/24/1987 | EP0226069A1 HLA-B 27, DNA coding therefor and its utilization |
| 06/23/1987 | US4675400 Bifunctional derivatives of 4-desacetyl indole-dihydroindole alkaloids |
| 06/23/1987 | US4675387 Lymphs + cells bilogical |
| 06/23/1987 | US4675385 Chromatography |
| 06/23/1987 | US4675384 Fractionation/purification of plasma by ion exchange chromatography |
| 06/23/1987 | US4675383 Purification of T-cell growth factor |
| 06/23/1987 | US4675382 Anticarcinogenic agents; polypeptide linkages |
| 06/23/1987 | US4675338 Peptide linkages with aspartic and glutamic acid; antitumor a gents |
| 06/23/1987 | US4675297 Genes encoding bovine prolactin |
| 06/23/1987 | US4675295 Process for producing subculturable lymphokine-producing human T cell hybridomas |
| 06/23/1987 | US4675291 Human cultured cell line |
| 06/23/1987 | US4675287 Monoclonal antibody directed to human ganglioside GD2 |
| 06/23/1987 | US4675285 Genetic engineering |
| 06/23/1987 | US4675196 Ion exchange resin |
| 06/23/1987 | US4675183 Method for solubilization of interferon |
| 06/23/1987 | US4675113 Affinity chromatography using dried calcium alginate-magnetite separation media in a magnetically stabilized fluidized bed |
| 06/23/1987 | CA1223382A1 Immobilization of proteins on polymeric supports |
| 06/23/1987 | CA1223252A1 Elastin hydrolyzate |
| 06/23/1987 | CA1223223A1 Streptokinase-coding recombinant vectors |
| 06/23/1987 | CA1223205A1 Process for removing lipoproteins using derivatized polyhydroxymethylene |
| 06/23/1987 | CA1223202A1 Fibronectin-physiologically active substance complex and method of preparation thereof |
| 06/23/1987 | CA1223201A1 Process for the preparation of the c1 inactivator and its use |
| 06/23/1987 | CA1223199A1 Partially purified osteogenic factor and process for preparing same from demineralized bone |
| 06/23/1987 | CA1223198A1 Repair of tissue in animals |
| 06/18/1987 | WO1987003689A1 Hybridoma's to human pluripotent granulocyte colony stimulating factor |
| 06/18/1987 | WO1987003619A1 PROCESS FOR ENHANCING TRANSLATIONAL EFFICIENCY OF EUKARYOTIC mRNA |
| 06/18/1987 | WO1987003601A1 Peptides capable of inhibiting the interactions between antigens and lymphocytes t4, products derived therefrom and application thereof |
| 06/18/1987 | WO1987003600A1 Cell-free t cell antigen receptor and its clinical utilities |
| 06/18/1987 | WO1987003487A1 Methods and materials for alleviation of pain symptoms of malignant neoplasia |
| 06/18/1987 | WO1987003485A1 Compositions for combatting diarrhoea |
| 06/17/1987 | CN86106234A Production of pluripotent granule cell colony stimulating factor |
| 06/16/1987 | US4673734 Porous mineral support coated with an aminated polysaccharide polymer |
| 06/16/1987 | US4673733 Treatment of biological and pharmaceutical products adsorbed on a solid phase with virus and pyrogen inactivating agents |
| 06/16/1987 | US4673732 A-human atrial natriuretic polypeptide; diaonosis of hypertension |
| 06/16/1987 | US4673634 Purified antigen from non-A, non-B hepatitis causing factor |
| 06/16/1987 | EP0225860A2 A method to export gene products to the growth medium of Gram negative bacteria |
| 06/16/1987 | EP0225701A1 Expression vector for an animal cell line and uses thereof |
| 06/16/1987 | EP0225648A2 Compositions of matter having highly potentiated antigenic activity |
| 06/16/1987 | EP0225633A2 Production of thrombin inhibitors |
| 06/16/1987 | EP0225583A2 Monoclonal anti-human granulocyte colony stimulating factor antibody |
| 06/16/1987 | EP0225579A2 Covalently linked polypeptide cell modulators |
| 06/16/1987 | CA1222952A1 Mixtures of fsh and lh from pig hypophyses in a definite ratio |
| 06/15/1987 | EP0148922A4 Hybrid dna synthesis of epidermal growth factor. |
| 06/11/1987 | DE3642050A1 New killer toxin |
| 06/11/1987 | DE3640042A1 Novel calcitonin derivatives |
| 06/10/1987 | EP0225311A2 4-Amino butanoic-acid derivatives, their preparation and their use |
| 06/10/1987 | EP0225286A2 Modified fibrinolytic agents |
| 06/10/1987 | EP0225156A2 Protein-folding enzyme |
| 06/10/1987 | EP0225109A2 Vasopressin antagonists |
| 06/10/1987 | EP0225066A2 Antigen determinant peptides and a process for the preparation thereof |
| 06/10/1987 | EP0225050A2 Automated biopolymer crystal preparation apparatus and process |
| 06/10/1987 | EP0225020A2 Peptides comprising, in sequence, units selected from the amino-acid residues 17 to 24 of ViP |
| 06/10/1987 | EP0224844A2 Process for producing peptides by the use of perchlorates |
| 06/10/1987 | EP0224811A2 Improved method of preparing alpha-1-proteinase inhibitor |
| 06/10/1987 | EP0224676A1 Medicament containing cardiodilatin produced by fermentation technology and process for the production thereof |
| 06/10/1987 | EP0224574A1 Autoantigen vaccines |
| 06/10/1987 | EP0224540A1 Products resulting from the conjugation of a macromolecular support, a hapten and a muramyl-peptide |
| 06/10/1987 | CN86106762A Novel dna and polypeptide |
| 06/09/1987 | US4672108 Crystalline human leukocyte interferon |
| 06/09/1987 | US4672054 Process for the preparation of angiotensin-II analogues substituted in the 1-, 5- and 8- positions |
| 06/09/1987 | US4672053 Immunoaffinity purification of phytolaccin proteins and their use in treating Herpes Simplex virus type II |
| 06/09/1987 | US4672032 Dental enamel production |
| 06/09/1987 | CA1222707A1 Preparation of hepatitis b virus vaccine |
| 06/09/1987 | CA1222706A1 Nucleic acid-protein conjugate |
| 06/09/1987 | CA1222693A1 Membrane-associated proteins (mp.sub.2), a process for obtaining them, and their use |
| 06/09/1987 | CA1222691A1 Method of preparing radionuclide-labelled proteins, in particular antibodies or antibody fragments |
| 06/04/1987 | WO1987003372A1 Diagnosis reagents |
| 06/04/1987 | WO1987003303A1 Agricultural-chemical-producing endosymbiotic microorganisms and method of preparing and using same |
| 06/04/1987 | WO1987003301A1 PURIFIED ANTIGENS HAVING VACCINATING PROPERTIES AGAINST B. PERTUSSIS, MEANS, PARTICULARLY RECOMBINANT DNAs FOR PRODUCING THEM, AND VACCINE COMPOSITIONS CONTAINING THEM |
| 06/04/1987 | WO1987003300A1 Enhanced secretion of heterologous proteins by hosts using substituted promoters |